Search

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

… Tuesday, October 1, 2013 Summary Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of. VIDEO | 00:14 The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design Video Details This movie clip shows Pseudomonas

Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs.

… Wednesday, December 19, 2012 Summary Scientists have identified genes and biological mechanisms that one day could be targeted with drugs to stop kidney cancer from spreading to the bone, brain, or other organs. Metastasis , the process by which some tumors spread from their site of origin to other body

After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that Lisa M. DeAngelis has been named Physician-in-Chief and Chief Medical Officer. A leading expert in brain cancer, Dr. DeAngelis previously served as Chair of the Department of Neurology and was co-founder of MSK’s Brain Tumor Center during her 30-plus-year tenure at the institution.

… Tuesday, September 10, 2019 Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK Lisa M. DeAngelis Has Been Named Physician-in-Chief and Chief Medical Officer of MSK After an extensive nationwide search, Memorial Sloan Kettering Cancer Center (MSK) announced today that

During the upcoming ASCO Virtual Scientific Program, MSK Medical Oncologist Zsofia K. Stadler, MD, will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted therapeutic interventions in a pan-cancer patient population, or a population with similarities and differences among the genomic and cellular alterations found across their diverse tumor types.

… Friday, May 29, 2020 During the American Society of Clinical Oncology (ASCO) Virtual Scientific Program , Memorial Sloan Kettering (MSK) Medical Oncologist Zsofia K. Stadler, MD , will present a study where she and her team sought to assess the clinical utility of germline mutation profiling for targeted

The David H. Koch Center for Cancer Care has recently been recognized by a number of industry leaders for its innovative and resilient design, some of the many features that put the 750,000 square foot facility in a class of its own.

… Friday, June 5, 2020 It’s been six months since members of the MSK Boards of Overseers and Managers, hospital leadership, and local elected officials joined together to celebrate the opening of the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center . Recently, the facility

Couldn’t be at ASCO this year? Read highlights from the first half of the meeting.

… Monday, June 6, 2016 Summary Among the highlights presented at this year’s American Society of Clinical Oncology annual meeting were advances in targeted therapy for small cell lung cancer, immunotherapy for non-small cell lung cancer, and insights into the biology of bladder cancer immunotherapy responders

After years of planning and anticipation, the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is scheduled to open in January 2020.

… Friday, December 6, 2019 After years of planning and anticipation, the  David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is scheduled to open in January 2020.   Located off York Avenue on 74th Street, the David H. Koch Center for Cancer Care at Memorial Sloan Kettering is

MSK infectious disease specialist Monika Shah debunks common myths about the flu shot.

… Friday, February 14, 2020 Summary Too many people neglect to get a flu shot every year, according to MSK infectious disease specialist Monika Shah. She explains why getting vaccinated is so essential. According to the Centers for Disease Control, flu activity has been higher than normal in the US this

For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Patients in the study were evaluated for up to 23 years after having the procedure, providing the longest follow-up results to date.

… Wednesday, February 22, 2012 For the first time, a new study has shown that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Patients in the study were evaluated for up to 23 years after having the procedure, providing the

Learn how MSK Direct — one of the nation's largest employer cancer benefits programs — made it easier for Steve Harrold to travel from Massachusetts to MSK for treatment days after a throat cancer diagnosis.

… Friday, March 28, 2025 Steve Harrold felt an immediate sense of dread as he watched the technician’s eyes widen during an image-guided scope of his throat. “I could tell that what she was looking at was not good,” he recalls. Steve had been experiencing slight difficulty swallowing, which he mentioned